Skip to main content
logo
ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
24.78
0.00 (0.00%)
Oct 5, 2025, 8:00 PM EDT

ResMed Revenue

In the fiscal year ending June 30, 2025, ResMed had annual revenue of $5.15B with 9.84% growth. ResMed had revenue of $1.35B in the quarter ending June 30, 2025, with 10.20% growth.

Revenue
5.15B
Revenue Growth
+9.84%
P/S Ratio
7.98
Revenue / Employee
485.50K
Employees
10,600
Market Cap
41.06B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20255.15B461.03M9.84%
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veradigm588.02M
Elite Pharmaceuticals105.45M
Glass House Brands221.55M
Northwest Biotherapeutics1.09M
American Oncology Network1.76B
Silence Therapeutics27.17M
Jushi Holdings256.36M
Nuo Therapeutics1.95M
Revenue Rankings

ResMed News

More News